← 返回

单细胞转录组学揭示了早发性和晚发性宫颈癌中多方面的免疫异质性

英文原题:Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer.

查看英文原题

Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer.

PubMed 2025/01/14(内容时间) World J Surg Oncol Q1 · IF 2.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

早发性宫颈癌(EOCC)和晚发性宫颈癌(LOCC)代表两种临床上不同的亚型,各自具有独特的临床表现和治疗反应。然而,它们的免疫学特征仍鲜有探索。在此,我们分析了4例EOCC和4例LOCC样本的单细胞转录组数据,以比较其免疫结构。EOCC中的上皮细胞表现出显著的双重免疫表型,其特征是由CXCL产生增加驱动的免疫抑制特性,同时伴有与HLA分子表达升高相关的免疫刺激特征。LOCC中的CD4+和CD8+T细胞表现出增强的活化状态,而NK细胞则表现出减弱的细胞毒性。LOCC中的巨噬细胞显示出向M1和M2表型增强的极化,同时树突状细胞表现出增强的抗原呈递能力。关于癌相关成纤维细胞(CAFs),EOCC富含炎症性CAFs,而LOCC则含有更高比例的抗原呈递CAFs。这些发现揭示了EOCC与LOCC之间多方面的免疫异质性,强调了制定年龄定制免疫治疗策略的必要性。

展开英文摘要原文

Early-onset (EOCC) and late-onset cervical cancers (LOCC) represent two clinically distinct subtypes, each defined by unique clinical manifestations and therapeutic responses.

However, their immunological profiles remain poorly explored.

Herein, we analyzed single-cell transcriptomic data from 4 EOCC and 4 LOCC samples to compare their immune architectures. Epithelial cells in EOCC exhibited a notable dual immunological phenotype, characterized by immune-suppressive properties driven by elevated CXCL production, alongside immune-stimulatory features linked to heightened HLA molecule expression.

CD4 + and CD8 + T cells in LOCC demonstrated a heightened activation state, while NK cells exhibited diminished cytotoxicity. Macrophages in LOCC displayed enhanced polarization towards both M1 and M2 phenotypes, along with dendritic cells showing augmented antigen-presenting capacity. Regarding cancer-associated fibroblasts (CAFs), EOCC was enriched with inflammatory CAFs, whereas LOCC harbored a higher proportion of antigen-presenting CAFs.

These findings reveal the multifaceted immune heterogeneity between EOCC and LOCC, underscoring the imperative for age-tailored immunotherapeutic strategies.

论文信息

作者
Chen Q、Deng D、Zhu H、Li S
第一作者单位
Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.China
通讯作者单位
Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China. lishan2016@csu.edu.cn.China
文献类型
对照研究
期刊
World journal of surgical oncology2025 Jan 14
原文标识
PubMed 39810181 · DOI 10.1186/s12957-025-03654-z